Department of Health and Social Care
New measures to support roll-out of vaccines in the UK
New laws allowing more healthcare workers to administer flu and potential COVID-19 vaccines have been introduced, the government recently (06 October 2020) announced.
- More healthcare workers will be trained to administer flu and COVID-19 vaccines safely to public
- Changes will help the UK-wide deployment of vaccines once they have been approved by the regulator
- Vaccines will only be given to patients once proven to be safe and effective
The measures aim to save thousands of lives by increasing access to vaccines against potentially killer diseases. They will also support the government’s plans for the roll-out of a potential COVID-19 vaccine that is proven to be safe and effective through robust clinical trials and approved for use by the regulator.
Following a public consultation, changes to the Human Medicines Regulations 2012 came into force recently (Friday 16 October 2020) which will:
- enable the expansion of the trained workforce who can administer COVID-19 and flu vaccines to improve access and protect the public. This will begin with those who already have experience in handling vaccinations but may currently work outside of NHS settings, such as independent nurses, allied healthcare professionals, paramedics, physiotherapists, pharmacists and student nurses and doctors. The expanded workforce will undergo a robust training programme to ensure patient safety is upheld to the highest standards
- implement reinforced safeguards to support the Medicines and Healthcare products Regulatory Agency (MHRA) to exceptionally grant temporary authorisation, pending the granting of a licence, for new vaccines and treatments needed to tackle public health threats – provided they meet the highest safety, quality and effectiveness standards and there’s a significant public health justification for doing so
Health Secretary Matt Hancock recently said:
The NHS has vast experience in vaccinating millions of people against diseases every year.
These legal changes will help us in doing everything we can to make sure we are ready to roll out a safe and effective COVID-19 vaccine as soon as it has passed clinical trials and undergone rigorous checks by the regulator.
We will be able to increase the number of fully trained and experienced healthcare professionals to administer COVID-19 and flu vaccines under NHS and local authority occupational health schemes, as well as enable an expanded workforce that can administer these vaccinations to the public. This will make it easier and quicker for patients and healthcare workers to access the vaccines they need, protecting them against fatal diseases.
Our planning will ensure this does not affect other services in hospitals and in GP and community services, by drawing on a pool of experienced NHS professionals through the NHS Bring Back Scheme. This will ensure we can provide a safe and effective vaccination programme while continuing to offer timely access to other NHS services.
Deputy Chief Medical Officer Professor Jonathan Van-Tam recently said:
COVID-19 vaccines are being developed at speed which, if successful, will save lives.
All vaccines must undergo 3 stages of clinical trials and be assessed for safety and effectiveness by the regulator before they are given to patients.
The measures outlined today aim to improve access and strengthen existing safeguards protecting patients.
If a vaccine is developed before 2021, the changes to the Human Medicine Regulations will bolster existing powers that enable the MHRA to authorise temporary supply for any treatment or vaccine needed to respond to a public health need.
This means that if a vaccine has been found to meet the safety, quality and effectiveness standards by the MHRA then vaccinations can begin without needing to wait for the European Medicines Agency who – up until the end of the transition period in 2021 – would have been the only body able to grant a licence.
Dr Christian Schneider, Interim Chief Scientific Officer at the Medicines and Healthcare products Regulatory Agency, recently said:
Patient safety is our top priority. The independent Commission on Human Medicines will advise the UK government on the safety, quality and effectiveness of any potential vaccine. No vaccine will be deployed unless stringent standards have been met through a comprehensive clinical trial programme.
The preferred route to enable deployment of any new vaccine remains through the usual product licensing processes.
But reinforced safeguards are now in place to strengthen the regulatory regime and our ability to protect public health, should temporary authorisations be necessary.
From 2021, the MHRA will have a national licensing system in place and will be responsible for granting licences for potential vaccines and treatments once they meet high standards of safety, quality and effectiveness.
See the formal response to the consultation.
The independent Joint Committee for Vaccination and Immunisation (JCVI) advises the government on which groups of people to prioritise for vaccination, based on the characteristics of the vaccine when that data is available. Read the latest JCVI advice.
The changes to the Human Medicines Regulations will also clarify the scope of the protection from civil liability for pharmaceutical companies and the additional workforce that could be allowed to administer vaccinations.
Latest News from
Department of Health and Social Care
More life-saving support for India on its way from UK07/05/2021 16:27:00
A cargo plane left Belfast today, carrying 3 surplus 18-tonne oxygen generators and 1,000 ventilators as part of the UK’s response to India’s COVID-19 crisis.
New cutting-edge testing centre to fast-track COVID-19 variant vaccines05/05/2021 12:10:00
New state-of-the-art labs will test the effectiveness of vaccines against new variants.
50 million doses of COVID-19 vaccine administered in UK04/05/2021 12:10:00
More than 34 million people have had at least one jab while 15 million have had both doses of the vaccine.
More women urged to come forward to shape women's health strategy04/05/2021 10:10:00
Women from under-represented groups urged to respond to call for evidence to shape the future of women’s healthcare.
Government to launch 40,000 person daily contact testing study04/05/2021 09:10:00
New study to offer daily rapid testing to contacts of positive COVID-19 cases.
Care homes residents allowed more out-of-home visits03/05/2021 10:25:00
Residents will be able to leave care homes for low-risk visits without needing to self-isolate on their return.
UK sends oxygen factories to support India30/04/2021 12:27:00
The UK will send further vital oxygen equipment to India in support of the country’s fight against coronavirus (COVID-19).
Health and Social Care Secretary's statement on coronavirus (COVID-19): 28 April 202130/04/2021 11:15:00
Speech given recently (28 April 2021) by Secretary of State for Health and Social Care Matt Hancock at the Downing Street coronavirus briefing.